Sensei Biotherapeutics Bilan de santé
Santé financière contrôle des critères 6/6
Sensei Biotherapeutics has a total shareholder equity of $52.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $59.8M and $7.6M respectively.
Informations clés
0%
Ratio d'endettement
US$0
Dette
Ratio de couverture des intérêts | n/a |
Argent liquide | US$52.29m |
Fonds propres | US$52.19m |
Total du passif | US$7.61m |
Total des actifs | US$59.80m |
Mises à jour récentes de la santé financière
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14Recent updates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14We're Hopeful That Sensei Biotherapeutics (NASDAQ:SNSE) Will Use Its Cash Wisely
Aug 14Sensei Biotherapeutics GAAP EPS of -$0.34 beats by $0.06
Aug 09Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Apr 18Sensei Biotherapeutics (NASDAQ:SNSE) Is In A Good Position To Deliver On Growth Plans
Nov 16Analyse de la situation financière
Passif à court terme: SNSE's short term assets ($53.9M) exceed its short term liabilities ($4.9M).
Passif à long terme: SNSE's short term assets ($53.9M) exceed its long term liabilities ($2.7M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: SNSE is debt free.
Réduire la dette: SNSE currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: SNSE has sufficient cash runway for more than a year based on its current free cash flow.
Prévisions de trésorerie: SNSE has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 16.5% each year.